Ainley, L., Law, S., Heptinstall, L., Rodriguez-Justo, M., Thomson, K., & Pepper, R. J. (2020). Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation. Kidney Int Rep.

Ainley, Louise, Steven Law, Lauren Heptinstall, Manuel Rodriguez-Justo, Kirsty Thomson, und Ruth J. Pepper. "Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation." Kidney Int Rep 2020.

Ainley, Louise, et al. "Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation." Kidney Int Rep 2020.